阿波利波蛋白E对阿尔茨海默病的血管贡献
Feng Chen1, Jing Zhao2, Fanxia Meng1
1Department of Neurology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Brain : a journal of neurology
|May 15, 2024
概括
阿尔茨海默病涉及脑血管功能障碍,其中阿波利波蛋白E (APOE) 起着关键作用. 本综述探讨了APOE对阿尔茨海默氏症病原学的影响,并提出了新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,目前的治疗方法不足以应对其进展.
- 既定的AD病理学侧重于粉样斑块和神经纤维状,但需要调查的替代机制.
- 脑血管功能障碍越来越被认为是AD病变的早期和重要因素.
研究的目的:
- 审查阿尔茨海默病中阿波利波蛋白E (APOE) 对脑血管的影响.
- 阐明APOE,特别是APOE ε4等位基因在AD相关的脑血管病理中的作用.
- 提出一个新的假设,用于AD病原体涉及大脑血管机制.
主要方法:
- 对APOE,脑血管功能和阿尔茨海默病研究的综合文献综述.
- 分析证据,将中央和外围APOE与AD病变发生联系起来.
- 为阿尔茨海默病制定一个新的病因学假设.
主要成果:
- 阿波利波蛋白E,特别是APOE ε4等位基因,与阿尔茨海默病的脑血管病理有很大关系.
- 脑血管功能障碍是AD的关键,通常是早期的组成部分.
- 该审查综合了支持APOE在AD中的多方面的作用的证据.
结论:
- 针对脑血管病理,特别是涉及APOE的机制,为阿尔茨海默病提供了一个有前途的治疗途径.
- 提出了一种新的三击假设,将大脑血管功能障碍纳入AD的病原体.
- 未来的研究应该专注于开发治疗方法,以解决AD中APOE介导的脑血管损伤.
相关概念视频
Alzheimer's Disease: Overview
467
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
467
Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181


